EMEA-000452-PIP02-10-M06
Key facts
Invented name |
|
Active substance |
tadalafil
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0376/2020
|
PIP number |
EMEA-000452-PIP02-10-M06
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of pulmonary arterial hypertension
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|